CNPAX
Price
$73.42
Change
+$0.12 (+0.16%)
Updated
Dec 4 closing price
Net Assets
162.64B
JESSX
Price
$17.68
Change
+$0.01 (+0.06%)
Updated
Dec 3 closing price
Net Assets
59.86M
Interact to see
Advertisement

CNPAX vs JESSX

Header iconCNPAX vs JESSX Comparison
Open Charts CNPAX vs JESSXBanner chart's image
American Funds New Perspective 529A
Price$73.42
Change+$0.12 (+0.16%)
VolumeN/A
Net Assets162.64B
Janus Henderson Global Sust Eq S
Price$17.68
Change+$0.01 (+0.06%)
VolumeN/A
Net Assets59.86M
CNPAX vs JESSX Comparison Chart in %
View a ticker or compare two or three
VS
CNPAX vs. JESSX commentary
Dec 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CNPAX is a Buy and JESSX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CNPAX has more cash in the bank: 163B vs. JESSX (59.9M). CNPAX pays higher dividends than JESSX: CNPAX (0.46) vs JESSX (0.15). CNPAX was incepted earlier than JESSX: CNPAX (24 years) vs JESSX (5 years). JESSX (6.21) is less costly to investors than CNPAX (0.77). JESSX (25.00) and CNPAX (24.00) have comparable annual turnover. CNPAX has a lower initial minimum investment than JESSX: CNPAX (250) vs JESSX (2500). CNPAX annual gain was more profitable for investors over the last year : 11.91 vs. JESSX (8.98). JESSX return over 5 years is better than : 42.49 vs. CNPAX (25.34).
CNPAXJESSXCNPAX / JESSX
Total Expense Ratio0.771.3657%
Annual Report Gross Expense Ratio0.776.2112%
Fund Existence24 years5 years-
Gain YTD20.10515.783127%
Front Load4%N/A-
Min. Initial Investment250250010%
Min. Initial Investment IRAN/AN/A-
Net Assets163B59.9M272,120%
Annual Yield % from dividends0.460.15310%
Returns for 1 year11.918.98133%
Returns for 3 years46.1049.0094%
Returns for 5 years25.3442.4960%
Returns for 10 years101.99N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CTNM11.120.63
+6.01%
Contineum Therapeutics
LOB33.281.11
+3.45%
Live Oak Bancshares
ALSN90.521.20
+1.34%
Allison Transmission Holdings
ATMVU7.75N/A
N/A
AlphaVest Acquisition Corp
CTSO0.73-0.04
-4.67%
Cytosorbents Corp